Streetbeat News

Stock Prices

CCL

Financial analysts have observed a bullish trend in options trading for Carnival (NYSE:CCL), with 55% of trades being bullish. The trading activity suggests investors are targeting a price range of $12.0 to $35.0 for CCL over the next three months. Notable options activity includes both calls and puts with varying sentiments and strike prices. Carnival, the largest global cruise company, has seen its stock price decrease by -2.84%, with an upcoming earnings announcement in 48 days. The company's trading volume and RSI indicators suggest it may be approaching oversold territory.

Portfolio Pulse from Benzinga Insights

May 07, 2024 | 7:45 pm

CELH

William H. Milmoe, co-chair and shareholder of Celsius Holdings, Inc. (NASDAQ:CELH), sold over $76 million worth of company stock ahead of its earnings report. The sales occurred from May 2 to May 6, with Milmoe offloading 214,287 shares each day at an average price of $59.66 per share. The transactions were disclosed in a Form 4 filing with the SEC. Milmoe still retains a significant stake in Celsius through CD Financial LLC and as a trustee of the Carl DeSantis Revocable Trust. The reason for the sale was not disclosed.

Portfolio Pulse from Aaron Bry

May 07, 2024 | 7:44 pm

RBT

Rubicon Technologies, Inc. (NYSE:RBT) experienced a stock price decline after announcing the sale of its fleet technology business to Rodina Capital for $94.2 million and the issuance of $20 million in convertible preferred stock. These transactions are aimed at improving the company's balance sheet, reducing debt, and increasing liquidity. Despite these strategic moves intended to bolster long-term sustainability and growth, the market response was negative, with shares dropping 13.84% to 30 cents.

Portfolio Pulse from vaishaliprayag@benzinga.com

May 07, 2024 | 7:36 pm

BA

EIS

USO

Israeli forces seized control of the Rafah crossing, escalating tensions with Hamas and complicating ceasefire negotiations. The U.S. has delayed military shipments to Israel, including precision-guided munitions from Boeing Co., as a sign of discontent with Israel's actions. The UN Secretary-General condemned the assault, warning of a humanitarian nightmare. Israeli stocks, including the iShares MSCI Israel ETF, rose, while oil prices remained stable, with the United States Oil Fund seeing a slight increase.

Portfolio Pulse from Piero Cingari

May 07, 2024 | 7:36 pm

ARKF

ARKW

COIN

HOOD

Mizuho analyst Dan Dolev reiterated a Buy rating on Robinhood Markets, Inc (HOOD) with a price target of $21, despite SEC challenges related to Robinhood Crypto. The concerns are deemed overblown, with historical context and financial metrics supporting a positive outlook. HOOD's stock has risen, reflecting market confidence. Coinbase Global, Inc (COIN) also saw a significant increase after receiving a Wells Notice. Robinhood's performance and valuation metrics are highlighted, with exposure to HOOD available through ARK ETFs ARKW and ARKF.

Portfolio Pulse from Anusuya Lahiri

May 07, 2024 | 7:36 pm

PFE

Pfizer shares are under scrutiny as traders react to a STAT News report about a young boy's death during a trial for Pfizer's Duchenne gene therapy. This incident raises concerns about the safety and future prospects of Pfizer's gene therapy program.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 7:31 pm

EXPE

Investors have shown a bullish stance on Expedia Group (NASDAQ:EXPE), as evidenced by significant options trading activity. Benzinga's options scanner revealed 8 notable trades, with a sentiment split between bullish and bearish. The trading focuses on a price band between $95.0 and $145.0. Analysts have set an average price target of $149.4 for EXPE, with various ratings from Neutral to Outperform. The stock's current trading volume is 2,923,830, with a recent price drop of -2.79%, indicating it may be oversold. An earnings announcement is expected in 86 days.

Portfolio Pulse from Benzinga Insights

May 07, 2024 | 7:30 pm

CVS

Deep-pocketed investors have shown a bearish sentiment towards CVS Health (NYSE:CVS), with options trading data from Benzinga indicating a significant move. The analysis of options activities reveals a mix of bullish (35%) and bearish (50%) sentiments among investors, with notable trades in both puts and calls within a price window of $50.0 to $92.5. CVS Health's current market status shows a slight price decrease with potential oversold conditions, and expert opinions vary with target prices ranging from $58 to $87.

Portfolio Pulse from Benzinga Insights

May 07, 2024 | 7:30 pm

AAPL

GOOG

NVDA

Apple Inc is reportedly developing its own AI chips, aiming to reduce reliance on external chip manufacturers like NVIDIA Corporation. This project, known as ACDC, involves collaboration with Taiwan Semiconductor Manufacturing Co. and focuses on AI inference within data centers, differing from NVIDIA's AI model training specialization. Apple's move mirrors a broader industry trend towards in-house chip development, as seen with other tech giants like Alphabet Inc's Google. Despite this shift, experts believe there will still be room for both Apple and NVIDIA in the AI market.

Portfolio Pulse from Aaron Bry

May 07, 2024 | 7:25 pm

TSLA

Tesla Inc (NASDAQ:TSLA) plans a temporary shutdown of its Giga Berlin factory due to upcoming protests against its expansion. The closure, initially reported as four days, is clarified to be effectively one day, considering a public holiday and existing work schedules. The protests aim to highlight environmental concerns over Tesla's expansion. Despite the brief pause, Tesla influencers believe it will not impact vehicle deliveries in Europe.

Portfolio Pulse from Chris Katje

May 07, 2024 | 7:20 pm